Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Benjamin Vallin

Postdoctoral neuronal cell biologist

I completed a PhD in Physiology, Physiopathology and Therapeutics at University Pierre et Marie Curie (Paris, France), in which I studied the role of cAMP signalling in pathological vascular remodelling. I then joined the group of Professor Roger Barker (Cambridge, UK) in 2018 to investigate post-transcriptional and post-translational modifications of alpha-synuclein in the context of Parkinson’s disease.

Building on this experience, I joined the Wade-Martins group in September 2021 and will study the transcriptional changes undergone by iPSC-derived dopaminergic neurons in response to patient-derived alpha-synuclein. We aim to describe and order the earliest events in the human neuronal response to pathological alpha-synuclein, which may help identify new targets for neuroprotective therapy.